Time Left - 12:00 mins
Attempt now to get your rank among 5682 students!
Question 1
Directions: Read the following passage carefully and answers the questions given below it.
Seventeen years after the first successful transplantation of cells harvested from the umbilical cord, the use of cord blood as a viable alternative to bone marrow as a sources of stem cells is gaining importance. The cord blood that remains in the placenta after birth is routinely discarded as waste despite the fact that it has sufficient quantity of stem cells capable of curing diseases. Although precise data are not available, it is thought that 5,000 to 6,000 cord blood transplantations have been performed worldwide. With the number of births in India running into several millions a year, the potential to fight disease and save lives is immense even if the cord blood from a small fraction of newborns can be collected and preserved. There are compelling reasons for saving cord blood – the avoidance of the need for a perfect tissue match required in bone marrow transplants, the low rate of viral contamination and ready availability. The scope for using the cord blood later in the event of the child suffering from certain diseases is also a major attraction.
It is this unique feature that has prompted some private companies in India, as in the developed countries, to get up facilities to collect and store cord blood, for a huge fee of course. Like their counterparts in the West, most of them resort to emotional marketing to sell the concept of cord blood serving as a biological insurance for use by the same child or another family member at a later date. How wise or relevant is it to save the newborn’s cord blood private banks? The answer is not clear as no reliable estimates of the demand for stored cord blood are available. Empirical data on such contingencies are also scarce. According to the American Academy of Pediatrics, the chances of a child needing his or her own cord blood to treat a disease vary from 1 in 1000 to 1 in 200, 000. While medicine as it is currently practiced does not allow use of a child’s cord blood in the treatment of his or her genetic or leukemia, it does have it uses in treating other diseases. Private cord blood banking is much more relevant where a member of the family may have a current or potential need for stem cell transplantation.
There is no disputing, the scientific fact the cord blood is a potential weapon to treat many diseases; and the number or diseases so treatable are likely, to increase in future. A good strategy might be to have several publicity funded cord blood banks co-existing with private banks. Modeled along the lines to blood banks, the public cord blood banks can draw on altruism to get voluntary donations; and since cord blood is far more expensive to process than blood, it can be made available to suitable recipients on payment of a reasonable collection, processing and storage charge. At least one private cord blood bank relying on voluntary donations is in place. Priority must be given to the training of doctors and staff in the proper collection techniques. This is of paramount importance as the time of clamping the umbilical cord to collect cord blood is critical. Clamping the cord too early will increase the volume of cord blood collected but leave the new-born with a reduced blood volume and an increased risk of anemia in later life. To prevent exploitation of poor and vulnerable people, getting the written consent of parents for cord collection as well as the institution of in – house ethics committees must be made mandatory, and the legal requirement strictly enforced.
Seventeen years after the first successful transplantation of cells harvested from the umbilical cord, the use of cord blood as a viable alternative to bone marrow as a sources of stem cells is gaining importance. The cord blood that remains in the placenta after birth is routinely discarded as waste despite the fact that it has sufficient quantity of stem cells capable of curing diseases. Although precise data are not available, it is thought that 5,000 to 6,000 cord blood transplantations have been performed worldwide. With the number of births in India running into several millions a year, the potential to fight disease and save lives is immense even if the cord blood from a small fraction of newborns can be collected and preserved. There are compelling reasons for saving cord blood – the avoidance of the need for a perfect tissue match required in bone marrow transplants, the low rate of viral contamination and ready availability. The scope for using the cord blood later in the event of the child suffering from certain diseases is also a major attraction.
It is this unique feature that has prompted some private companies in India, as in the developed countries, to get up facilities to collect and store cord blood, for a huge fee of course. Like their counterparts in the West, most of them resort to emotional marketing to sell the concept of cord blood serving as a biological insurance for use by the same child or another family member at a later date. How wise or relevant is it to save the newborn’s cord blood private banks? The answer is not clear as no reliable estimates of the demand for stored cord blood are available. Empirical data on such contingencies are also scarce. According to the American Academy of Pediatrics, the chances of a child needing his or her own cord blood to treat a disease vary from 1 in 1000 to 1 in 200, 000. While medicine as it is currently practiced does not allow use of a child’s cord blood in the treatment of his or her genetic or leukemia, it does have it uses in treating other diseases. Private cord blood banking is much more relevant where a member of the family may have a current or potential need for stem cell transplantation.
There is no disputing, the scientific fact the cord blood is a potential weapon to treat many diseases; and the number or diseases so treatable are likely, to increase in future. A good strategy might be to have several publicity funded cord blood banks co-existing with private banks. Modeled along the lines to blood banks, the public cord blood banks can draw on altruism to get voluntary donations; and since cord blood is far more expensive to process than blood, it can be made available to suitable recipients on payment of a reasonable collection, processing and storage charge. At least one private cord blood bank relying on voluntary donations is in place. Priority must be given to the training of doctors and staff in the proper collection techniques. This is of paramount importance as the time of clamping the umbilical cord to collect cord blood is critical. Clamping the cord too early will increase the volume of cord blood collected but leave the new-born with a reduced blood volume and an increased risk of anemia in later life. To prevent exploitation of poor and vulnerable people, getting the written consent of parents for cord collection as well as the institution of in – house ethics committees must be made mandatory, and the legal requirement strictly enforced.
Private companies indulge in emotional marketing:
Question 2
Directions: Read the following passage carefully and answers the questions given below it.
Seventeen years after the first successful transplantation of cells harvested from the umbilical cord, the use of cord blood as a viable alternative to bone marrow as a sources of stem cells is gaining importance. The cord blood that remains in the placenta after birth is routinely discarded as waste despite the fact that it has sufficient quantity of stem cells capable of curing diseases. Although precise data are not available, it is thought that 5,000 to 6,000 cord blood transplantations have been performed worldwide. With the number of births in India running into several millions a year, the potential to fight disease and save lives is immense even if the cord blood from a small fraction of newborns can be collected and preserved. There are compelling reasons for saving cord blood – the avoidance of the need for a perfect tissue match required in bone marrow transplants, the low rate of viral contamination and ready availability. The scope for using the cord blood later in the event of the child suffering from certain diseases is also a major attraction.
It is this unique feature that has prompted some private companies in India, as in the developed countries, to get up facilities to collect and store cord blood, for a huge fee of course. Like their counterparts in the West, most of them resort to emotional marketing to sell the concept of cord blood serving as a biological insurance for use by the same child or another family member at a later date. How wise or relevant is it to save the newborn’s cord blood private banks? The answer is not clear as no reliable estimates of the demand for stored cord blood are available. Empirical data on such contingencies are also scarce. According to the American Academy of Pediatrics, the chances of a child needing his or her own cord blood to treat a disease vary from 1 in 1000 to 1 in 200, 000. While medicine as it is currently practiced does not allow use of a child’s cord blood in the treatment of his or her genetic or leukemia, it does have it uses in treating other diseases. Private cord blood banking is much more relevant where a member of the family may have a current or potential need for stem cell transplantation.
There is no disputing, the scientific fact the cord blood is a potential weapon to treat many diseases; and the number or diseases so treatable are likely, to increase in future. A good strategy might be to have several publicity funded cord blood banks co-existing with private banks. Modeled along the lines to blood banks, the public cord blood banks can draw on altruism to get voluntary donations; and since cord blood is far more expensive to process than blood, it can be made available to suitable recipients on payment of a reasonable collection, processing and storage charge. At least one private cord blood bank relying on voluntary donations is in place. Priority must be given to the training of doctors and staff in the proper collection techniques. This is of paramount importance as the time of clamping the umbilical cord to collect cord blood is critical. Clamping the cord too early will increase the volume of cord blood collected but leave the new-born with a reduced blood volume and an increased risk of anemia in later life. To prevent exploitation of poor and vulnerable people, getting the written consent of parents for cord collection as well as the institution of in – house ethics committees must be made mandatory, and the legal requirement strictly enforced.
Seventeen years after the first successful transplantation of cells harvested from the umbilical cord, the use of cord blood as a viable alternative to bone marrow as a sources of stem cells is gaining importance. The cord blood that remains in the placenta after birth is routinely discarded as waste despite the fact that it has sufficient quantity of stem cells capable of curing diseases. Although precise data are not available, it is thought that 5,000 to 6,000 cord blood transplantations have been performed worldwide. With the number of births in India running into several millions a year, the potential to fight disease and save lives is immense even if the cord blood from a small fraction of newborns can be collected and preserved. There are compelling reasons for saving cord blood – the avoidance of the need for a perfect tissue match required in bone marrow transplants, the low rate of viral contamination and ready availability. The scope for using the cord blood later in the event of the child suffering from certain diseases is also a major attraction.
It is this unique feature that has prompted some private companies in India, as in the developed countries, to get up facilities to collect and store cord blood, for a huge fee of course. Like their counterparts in the West, most of them resort to emotional marketing to sell the concept of cord blood serving as a biological insurance for use by the same child or another family member at a later date. How wise or relevant is it to save the newborn’s cord blood private banks? The answer is not clear as no reliable estimates of the demand for stored cord blood are available. Empirical data on such contingencies are also scarce. According to the American Academy of Pediatrics, the chances of a child needing his or her own cord blood to treat a disease vary from 1 in 1000 to 1 in 200, 000. While medicine as it is currently practiced does not allow use of a child’s cord blood in the treatment of his or her genetic or leukemia, it does have it uses in treating other diseases. Private cord blood banking is much more relevant where a member of the family may have a current or potential need for stem cell transplantation.
There is no disputing, the scientific fact the cord blood is a potential weapon to treat many diseases; and the number or diseases so treatable are likely, to increase in future. A good strategy might be to have several publicity funded cord blood banks co-existing with private banks. Modeled along the lines to blood banks, the public cord blood banks can draw on altruism to get voluntary donations; and since cord blood is far more expensive to process than blood, it can be made available to suitable recipients on payment of a reasonable collection, processing and storage charge. At least one private cord blood bank relying on voluntary donations is in place. Priority must be given to the training of doctors and staff in the proper collection techniques. This is of paramount importance as the time of clamping the umbilical cord to collect cord blood is critical. Clamping the cord too early will increase the volume of cord blood collected but leave the new-born with a reduced blood volume and an increased risk of anemia in later life. To prevent exploitation of poor and vulnerable people, getting the written consent of parents for cord collection as well as the institution of in – house ethics committees must be made mandatory, and the legal requirement strictly enforced.
From this passage we can infer that:
Question 3
Directions: Read the following passage carefully and answers the questions given below it.
Seventeen years after the first successful transplantation of cells harvested from the umbilical cord, the use of cord blood as a viable alternative to bone marrow as a sources of stem cells is gaining importance. The cord blood that remains in the placenta after birth is routinely discarded as waste despite the fact that it has sufficient quantity of stem cells capable of curing diseases. Although precise data are not available, it is thought that 5,000 to 6,000 cord blood transplantations have been performed worldwide. With the number of births in India running into several millions a year, the potential to fight disease and save lives is immense even if the cord blood from a small fraction of newborns can be collected and preserved. There are compelling reasons for saving cord blood – the avoidance of the need for a perfect tissue match required in bone marrow transplants, the low rate of viral contamination and ready availability. The scope for using the cord blood later in the event of the child suffering from certain diseases is also a major attraction.
It is this unique feature that has prompted some private companies in India, as in the developed countries, to get up facilities to collect and store cord blood, for a huge fee of course. Like their counterparts in the West, most of them resort to emotional marketing to sell the concept of cord blood serving as a biological insurance for use by the same child or another family member at a later date. How wise or relevant is it to save the newborn’s cord blood private banks? The answer is not clear as no reliable estimates of the demand for stored cord blood are available. Empirical data on such contingencies are also scarce. According to the American Academy of Pediatrics, the chances of a child needing his or her own cord blood to treat a disease vary from 1 in 1000 to 1 in 200, 000. While medicine as it is currently practiced does not allow use of a child’s cord blood in the treatment of his or her genetic or leukemia, it does have it uses in treating other diseases. Private cord blood banking is much more relevant where a member of the family may have a current or potential need for stem cell transplantation.
There is no disputing, the scientific fact the cord blood is a potential weapon to treat many diseases; and the number or diseases so treatable are likely, to increase in future. A good strategy might be to have several publicity funded cord blood banks co-existing with private banks. Modeled along the lines to blood banks, the public cord blood banks can draw on altruism to get voluntary donations; and since cord blood is far more expensive to process than blood, it can be made available to suitable recipients on payment of a reasonable collection, processing and storage charge. At least one private cord blood bank relying on voluntary donations is in place. Priority must be given to the training of doctors and staff in the proper collection techniques. This is of paramount importance as the time of clamping the umbilical cord to collect cord blood is critical. Clamping the cord too early will increase the volume of cord blood collected but leave the new-born with a reduced blood volume and an increased risk of anemia in later life. To prevent exploitation of poor and vulnerable people, getting the written consent of parents for cord collection as well as the institution of in – house ethics committees must be made mandatory, and the legal requirement strictly enforced.
Seventeen years after the first successful transplantation of cells harvested from the umbilical cord, the use of cord blood as a viable alternative to bone marrow as a sources of stem cells is gaining importance. The cord blood that remains in the placenta after birth is routinely discarded as waste despite the fact that it has sufficient quantity of stem cells capable of curing diseases. Although precise data are not available, it is thought that 5,000 to 6,000 cord blood transplantations have been performed worldwide. With the number of births in India running into several millions a year, the potential to fight disease and save lives is immense even if the cord blood from a small fraction of newborns can be collected and preserved. There are compelling reasons for saving cord blood – the avoidance of the need for a perfect tissue match required in bone marrow transplants, the low rate of viral contamination and ready availability. The scope for using the cord blood later in the event of the child suffering from certain diseases is also a major attraction.
It is this unique feature that has prompted some private companies in India, as in the developed countries, to get up facilities to collect and store cord blood, for a huge fee of course. Like their counterparts in the West, most of them resort to emotional marketing to sell the concept of cord blood serving as a biological insurance for use by the same child or another family member at a later date. How wise or relevant is it to save the newborn’s cord blood private banks? The answer is not clear as no reliable estimates of the demand for stored cord blood are available. Empirical data on such contingencies are also scarce. According to the American Academy of Pediatrics, the chances of a child needing his or her own cord blood to treat a disease vary from 1 in 1000 to 1 in 200, 000. While medicine as it is currently practiced does not allow use of a child’s cord blood in the treatment of his or her genetic or leukemia, it does have it uses in treating other diseases. Private cord blood banking is much more relevant where a member of the family may have a current or potential need for stem cell transplantation.
There is no disputing, the scientific fact the cord blood is a potential weapon to treat many diseases; and the number or diseases so treatable are likely, to increase in future. A good strategy might be to have several publicity funded cord blood banks co-existing with private banks. Modeled along the lines to blood banks, the public cord blood banks can draw on altruism to get voluntary donations; and since cord blood is far more expensive to process than blood, it can be made available to suitable recipients on payment of a reasonable collection, processing and storage charge. At least one private cord blood bank relying on voluntary donations is in place. Priority must be given to the training of doctors and staff in the proper collection techniques. This is of paramount importance as the time of clamping the umbilical cord to collect cord blood is critical. Clamping the cord too early will increase the volume of cord blood collected but leave the new-born with a reduced blood volume and an increased risk of anemia in later life. To prevent exploitation of poor and vulnerable people, getting the written consent of parents for cord collection as well as the institution of in – house ethics committees must be made mandatory, and the legal requirement strictly enforced.
Which of the following has not been cited as a reason to promote the use of cord blood?
Question 4
Directions: Read the following passage carefully and answers the questions given below it.
Seventeen years after the first successful transplantation of cells harvested from the umbilical cord, the use of cord blood as a viable alternative to bone marrow as a sources of stem cells is gaining importance. The cord blood that remains in the placenta after birth is routinely discarded as waste despite the fact that it has sufficient quantity of stem cells capable of curing diseases. Although precise data are not available, it is thought that 5,000 to 6,000 cord blood transplantations have been performed worldwide. With the number of births in India running into several millions a year, the potential to fight disease and save lives is immense even if the cord blood from a small fraction of newborns can be collected and preserved. There are compelling reasons for saving cord blood – the avoidance of the need for a perfect tissue match required in bone marrow transplants, the low rate of viral contamination and ready availability. The scope for using the cord blood later in the event of the child suffering from certain diseases is also a major attraction.
It is this unique feature that has prompted some private companies in India, as in the developed countries, to get up facilities to collect and store cord blood, for a huge fee of course. Like their counterparts in the West, most of them resort to emotional marketing to sell the concept of cord blood serving as a biological insurance for use by the same child or another family member at a later date. How wise or relevant is it to save the newborn’s cord blood private banks? The answer is not clear as no reliable estimates of the demand for stored cord blood are available. Empirical data on such contingencies are also scarce. According to the American Academy of Pediatrics, the chances of a child needing his or her own cord blood to treat a disease vary from 1 in 1000 to 1 in 200, 000. While medicine as it is currently practiced does not allow use of a child’s cord blood in the treatment of his or her genetic or leukemia, it does have it uses in treating other diseases. Private cord blood banking is much more relevant where a member of the family may have a current or potential need for stem cell transplantation.
There is no disputing, the scientific fact the cord blood is a potential weapon to treat many diseases; and the number or diseases so treatable are likely, to increase in future. A good strategy might be to have several publicity funded cord blood banks co-existing with private banks. Modeled along the lines to blood banks, the public cord blood banks can draw on altruism to get voluntary donations; and since cord blood is far more expensive to process than blood, it can be made available to suitable recipients on payment of a reasonable collection, processing and storage charge. At least one private cord blood bank relying on voluntary donations is in place. Priority must be given to the training of doctors and staff in the proper collection techniques. This is of paramount importance as the time of clamping the umbilical cord to collect cord blood is critical. Clamping the cord too early will increase the volume of cord blood collected but leave the new-born with a reduced blood volume and an increased risk of anemia in later life. To prevent exploitation of poor and vulnerable people, getting the written consent of parents for cord collection as well as the institution of in – house ethics committees must be made mandatory, and the legal requirement strictly enforced.
Seventeen years after the first successful transplantation of cells harvested from the umbilical cord, the use of cord blood as a viable alternative to bone marrow as a sources of stem cells is gaining importance. The cord blood that remains in the placenta after birth is routinely discarded as waste despite the fact that it has sufficient quantity of stem cells capable of curing diseases. Although precise data are not available, it is thought that 5,000 to 6,000 cord blood transplantations have been performed worldwide. With the number of births in India running into several millions a year, the potential to fight disease and save lives is immense even if the cord blood from a small fraction of newborns can be collected and preserved. There are compelling reasons for saving cord blood – the avoidance of the need for a perfect tissue match required in bone marrow transplants, the low rate of viral contamination and ready availability. The scope for using the cord blood later in the event of the child suffering from certain diseases is also a major attraction.
It is this unique feature that has prompted some private companies in India, as in the developed countries, to get up facilities to collect and store cord blood, for a huge fee of course. Like their counterparts in the West, most of them resort to emotional marketing to sell the concept of cord blood serving as a biological insurance for use by the same child or another family member at a later date. How wise or relevant is it to save the newborn’s cord blood private banks? The answer is not clear as no reliable estimates of the demand for stored cord blood are available. Empirical data on such contingencies are also scarce. According to the American Academy of Pediatrics, the chances of a child needing his or her own cord blood to treat a disease vary from 1 in 1000 to 1 in 200, 000. While medicine as it is currently practiced does not allow use of a child’s cord blood in the treatment of his or her genetic or leukemia, it does have it uses in treating other diseases. Private cord blood banking is much more relevant where a member of the family may have a current or potential need for stem cell transplantation.
There is no disputing, the scientific fact the cord blood is a potential weapon to treat many diseases; and the number or diseases so treatable are likely, to increase in future. A good strategy might be to have several publicity funded cord blood banks co-existing with private banks. Modeled along the lines to blood banks, the public cord blood banks can draw on altruism to get voluntary donations; and since cord blood is far more expensive to process than blood, it can be made available to suitable recipients on payment of a reasonable collection, processing and storage charge. At least one private cord blood bank relying on voluntary donations is in place. Priority must be given to the training of doctors and staff in the proper collection techniques. This is of paramount importance as the time of clamping the umbilical cord to collect cord blood is critical. Clamping the cord too early will increase the volume of cord blood collected but leave the new-born with a reduced blood volume and an increased risk of anemia in later life. To prevent exploitation of poor and vulnerable people, getting the written consent of parents for cord collection as well as the institution of in – house ethics committees must be made mandatory, and the legal requirement strictly enforced.
The author is in favor of setting up cord blood
Question 5
Directions: Read the following passage carefully and answers the questions given below it.
Seventeen years after the first successful transplantation of cells harvested from the umbilical cord, the use of cord blood as a viable alternative to bone marrow as a sources of stem cells is gaining importance. The cord blood that remains in the placenta after birth is routinely discarded as waste despite the fact that it has sufficient quantity of stem cells capable of curing diseases. Although precise data are not available, it is thought that 5,000 to 6,000 cord blood transplantations have been performed worldwide. With the number of births in India running into several millions a year, the potential to fight disease and save lives is immense even if the cord blood from a small fraction of newborns can be collected and preserved. There are compelling reasons for saving cord blood – the avoidance of the need for a perfect tissue match required in bone marrow transplants, the low rate of viral contamination and ready availability. The scope for using the cord blood later in the event of the child suffering from certain diseases is also a major attraction.
It is this unique feature that has prompted some private companies in India, as in the developed countries, to get up facilities to collect and store cord blood, for a huge fee of course. Like their counterparts in the West, most of them resort to emotional marketing to sell the concept of cord blood serving as a biological insurance for use by the same child or another family member at a later date. How wise or relevant is it to save the newborn’s cord blood private banks? The answer is not clear as no reliable estimates of the demand for stored cord blood are available. Empirical data on such contingencies are also scarce. According to the American Academy of Pediatrics, the chances of a child needing his or her own cord blood to treat a disease vary from 1 in 1000 to 1 in 200, 000. While medicine as it is currently practiced does not allow use of a child’s cord blood in the treatment of his or her genetic or leukemia, it does have it uses in treating other diseases. Private cord blood banking is much more relevant where a member of the family may have a current or potential need for stem cell transplantation.
There is no disputing, the scientific fact the cord blood is a potential weapon to treat many diseases; and the number or diseases so treatable are likely, to increase in future. A good strategy might be to have several publicity funded cord blood banks co-existing with private banks. Modeled along the lines to blood banks, the public cord blood banks can draw on altruism to get voluntary donations; and since cord blood is far more expensive to process than blood, it can be made available to suitable recipients on payment of a reasonable collection, processing and storage charge. At least one private cord blood bank relying on voluntary donations is in place. Priority must be given to the training of doctors and staff in the proper collection techniques. This is of paramount importance as the time of clamping the umbilical cord to collect cord blood is critical. Clamping the cord too early will increase the volume of cord blood collected but leave the new-born with a reduced blood volume and an increased risk of anemia in later life. To prevent exploitation of poor and vulnerable people, getting the written consent of parents for cord collection as well as the institution of in – house ethics committees must be made mandatory, and the legal requirement strictly enforced.
Seventeen years after the first successful transplantation of cells harvested from the umbilical cord, the use of cord blood as a viable alternative to bone marrow as a sources of stem cells is gaining importance. The cord blood that remains in the placenta after birth is routinely discarded as waste despite the fact that it has sufficient quantity of stem cells capable of curing diseases. Although precise data are not available, it is thought that 5,000 to 6,000 cord blood transplantations have been performed worldwide. With the number of births in India running into several millions a year, the potential to fight disease and save lives is immense even if the cord blood from a small fraction of newborns can be collected and preserved. There are compelling reasons for saving cord blood – the avoidance of the need for a perfect tissue match required in bone marrow transplants, the low rate of viral contamination and ready availability. The scope for using the cord blood later in the event of the child suffering from certain diseases is also a major attraction.
It is this unique feature that has prompted some private companies in India, as in the developed countries, to get up facilities to collect and store cord blood, for a huge fee of course. Like their counterparts in the West, most of them resort to emotional marketing to sell the concept of cord blood serving as a biological insurance for use by the same child or another family member at a later date. How wise or relevant is it to save the newborn’s cord blood private banks? The answer is not clear as no reliable estimates of the demand for stored cord blood are available. Empirical data on such contingencies are also scarce. According to the American Academy of Pediatrics, the chances of a child needing his or her own cord blood to treat a disease vary from 1 in 1000 to 1 in 200, 000. While medicine as it is currently practiced does not allow use of a child’s cord blood in the treatment of his or her genetic or leukemia, it does have it uses in treating other diseases. Private cord blood banking is much more relevant where a member of the family may have a current or potential need for stem cell transplantation.
There is no disputing, the scientific fact the cord blood is a potential weapon to treat many diseases; and the number or diseases so treatable are likely, to increase in future. A good strategy might be to have several publicity funded cord blood banks co-existing with private banks. Modeled along the lines to blood banks, the public cord blood banks can draw on altruism to get voluntary donations; and since cord blood is far more expensive to process than blood, it can be made available to suitable recipients on payment of a reasonable collection, processing and storage charge. At least one private cord blood bank relying on voluntary donations is in place. Priority must be given to the training of doctors and staff in the proper collection techniques. This is of paramount importance as the time of clamping the umbilical cord to collect cord blood is critical. Clamping the cord too early will increase the volume of cord blood collected but leave the new-born with a reduced blood volume and an increased risk of anemia in later life. To prevent exploitation of poor and vulnerable people, getting the written consent of parents for cord collection as well as the institution of in – house ethics committees must be made mandatory, and the legal requirement strictly enforced.
Cord blood banks can draw on altruism to get voluntary donations means:
Question 6
Directions: What value will come in place of question mark (?) in the number series given below?
21 2765 4493 5493 6005 ?
Question 7
Direction: What should come of the question mark (?) in the following number series?
1220, 1232, 1208, 1244, 1196, ?
Question 8
Direction: What will come in place of the question marks (?) in the following Number series?
1, 2, 6, 21, 88, (?)
Question 9
Direction: What will come in place of question mark (?) in the following series?
210, 209, 213, 186, 202, ?
210, 209, 213, 186, 202, ?
Question 10
Direction: What will come in place of the question mark (?) in the following number series?
3, 42, 504, ?, 40320, 241920, 967680
Question 11
Direction: In the following question, some statements are followed by some conclusions. Assuming the given statements to be true, find which of the two conclusions follow(s) the given statements and choose appropriate answer choice.
Statements:
M < O ≤ P = S ≥ T > D ≥E, F ≤ O < G
Conclusions:
I. P > E
II. G ≤ D
M < O ≤ P = S ≥ T > D ≥E, F ≤ O < G
Conclusions:
I. P > E
II. G ≤ D
Question 12
Direction: In each of these question, the relationships between two or more elements are shown in the statements. These statements are followed by two conclusions. Read the statements and give answer
Statements:
A > R = S > T < U, V > S < Q
Conclusions:
I. R < Q
II. A < U
A > R = S > T < U, V > S < Q
Conclusions:
I. R < Q
II. A < U
Question 13
Which of the following symbols should replace the question mark in the given expression in order to make the expressions 'S > K' as well as 'P > R' definitely true?
S > T ≥ R ? K < M = P
S > T ≥ R ? K < M = P
Question 14
Direction: In the following question, some statements are followed by some conclusions. Assuming the given statements to be true, find which of the two conclusions follow(s) the given statements and choose appropriate answer choice.
Statement:
A > C ≥ D, R > S ≥ A, T = P < R
Conclusion:
I. P > D
II. C > T
A > C ≥ D, R > S ≥ A, T = P < R
Conclusion:
I. P > D
II. C > T
Question 15
Which of the following expressions is definitely true if the given expressions 'O < M’ as well as ‘P>N’ are definitely true?
- 5682 attempts
- 30 upvotes
- 178 comments
Jun 25PO, Clerk, SO, Insurance
